ArticleIndian dermatology online journal
A Study to Delineate the Immunohistological Parameters of Active Versus Stable Vitiligo Using S100, Melan A in Conjunction with CD4 and CD8 Immunohistochemistry Markers.
Article in Indian dermatology online journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitiligo is an autoimmune pigmentary disorder where it is important to assess the disease status (active/stable) to guide therapeutic decisions. Aim and Objectives: We aimed to compare expression of Melan A and S100 in active and stable vitiligo lesions and correlate them with CD4 and CD8 T cells. Patients and Methods: Skin biopsies from 45 clinically diagnosed vitiligo patients (25 active and 20 stable) were taken for histopathological analysis. Immunohistochemistry expression for Langerhans cells (S-100), melanocytes (Melan A), and CD4 and CD8 T cells was compared between active and stable vitiligo. Results: Basal cell layer vacuolization and dermal melanophages were more common in active vitiligo ( Limitations: The limitations of the study include small sample size and lack of control group. There could also be a chance of recall bias in the history given by patient regarding the duration of activity which may have resulted in the misclassification of active versus stable vitiligo. Conclusion: We found increased disease activity in the center and margins of active lesions of vitiligo, which can be discerned by decreased expression of Melan A and CD4 as well as an increased expression of S100 and CD8 with concomitant increased basal cell layer vacuolization and dermal melanophages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.